Endodermal and Hepatic Differentiation from Human Embryonic Stem Cells and Human Induced Pluripotent Stem CellsKenji Kawabata1,2, Kazuo Takayama1,3, Yasuto Nagamoto1,3, Mary S. Saldon1, Maiko Higuchi1 and Hiroyuki Mizuguchi1,3,4*
- Corresponding Author:
- Dr. Hiroyuki Mizuguchi
Laboratory of Biochemistry and Molecular Biology
Graduate School of Pharmaceutical Sciences
Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan
E-mail: [email protected]
Received Date: November 14, 2011; Accepted Date: January 21, 2012; Published Date: January 23, 2012
Citation: Kawabata K, Takayama K, Nagamoto Y, Saldon MS, Higuchi M, et al. (2012) Endodermal and Hepatic Differentiation from Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells. J Stem Cell Res Ther S10:002. doi:10.4172/2157-7633.S10-002
Copyright: © 2012 Kawabata K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Induced hepatocytes differentiated from human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) have a wide range of potential applications in biomedical research, drug discovery, and the treatment of liver disease. Differentiation of human ESCs and iPSCs into endodermal and hepatic cell types has been achieved by several methods, including addition of soluble factors into culture medium, transduction of differentiation-related genes, co-cultivation with other lineage cells, and a three-dimensional culture system. Each of these methods has an advantage from various points of view, such as the degree of maturation of differentiated hepatocytes, differentiation efficiency, clinical safety, and ease of handling. Currently, it is possible to select or combine the differentiation protocols to obtain ideal hepatocytes. The aim of this review is to describe the recent progress in endodermal and hepatic differentiation protocols from human ESCs and iPSCs in order to foster the suitable choice of induced hepatocytes on clinical and industrial applications.